To study the Efficacy of Bharangydi Chewable Tablets in Garbhini Kaasa(Cough in Pregnancy)

Evaluation of the Efficacy of Bharangydi Chewable Tablets in Garbhini Kaasa(Cough in Pregnancy) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085085

Enrollment

Registered

2025-04-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women primi and multigravida in all trimester, SpO2 Saturation more than 95-100%, Respiration rate 18-22/min , patients with lakshana of Productive cough and sore throat

Exclusion criteria

Exclusion criteria: Excessive cough and abnormal saturation with chest pain and wheeze, history of other pulmonary disease like pulmonary tuberculosis and Covid -19, known case of asthma, pneumonia in current pregnancy, known case of diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Effect of Bharangydi Chewable Tablets in Garbhini Kaasa which will be assessed by the symptoms productive cough and sore throatTimepoint: 7 days study with follow up on 4th and 7th day	—

Secondary

Measure	Time frame
To observe the adverse effect of Bharangydi Chewable TabletsTimepoint: 7 days study with follow up on 4th and 7th day	—

Countries

India

Contacts

Public ContactDrSmritika Taware

Dr.D Y Patil College of Ayurved and Research Centre Pimpri Pune

bhonsalesmritika@gmail.com9850967067

Outcome results